This study is in progress, not accepting new patients
Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Gary Schiller
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Gary Schiller
Professor-in-Residence, Medicine. Authored (or co-authored) 146 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- GlycoMimetics Incorporated
- ID
- NCT03616470
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 388 people participating
- Last Updated